SNOA - Sonoma Pharmaceuticals GAAP EPS of -$0.62 revenue of $2.94M February, 14 2023 04:59 PM Sonoma Pharmaceuticals Inc. Sonoma Pharmaceuticals press release ( NASDAQ: SNOA ): Q3 GAAP EPS of -$0.62. Revenue of $2.94M (+1.4% Y/Y). For further details see: Sonoma Pharmaceuticals GAAP EPS of -$0.62, revenue of $2.94M